[Federal Register Volume 70, Number 187 (Wednesday, September 28, 2005)]
[Notices]
[Pages 56723-56724]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-19386]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Director's Council of Public Representatives.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Director's Council of Public Representatives.
    Date: October 25, 2005.
    Time: 8:30 a.m. to 3 p.m.
    Agenda: Among the topics proposed for discussion are: (1) NIH 
Director's update; (2) COPR workgroup reports; (3) public 
perspective on the NIH Roadmap; (4) updates on the NIH Re-
authorization and the Office of Portfolio Analysis and Strategic 
Initiatives; (5) NIH response to COPR's Public Trust Report; and (6) 
discussion and public comment.
    Place: National Institutes of Health, Building 31, Conference 
Room 6, 9000 Rockville Pike, Bethesda, MD 20892.
    Contact Person: Jennifer E. Gorman Vetter, NIH Public Liaison/
COPR Coordinator, Office of Communications and Public Liaison, 
Office of the Director, National Institutes of Health, 9000 
Rockville Pike, Building 1, Room 344, Bethesda, MD 20892. (301) 435-
4448. [email protected].

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this

[[Page 56724]]

notice at least 10 days in advance of the meeting. Interested 
individuals and representatives of organizations may submit a letter 
of intent, a brief description of the organization represented, and 
a short description of the oral presentation. Only one 
representative of an organization may be allowed to present oral 
comments and if accepted by the committee, presentations may be 
limited to five minutes. Both printed and electronic copies are 
requested for the record. In addition, any interested person may 
file written comments with the committee by forwarding their 
statement to the Contact Person listed on this notice. The statement 
should include the name, address, telephone number and when 
applicable, the business or professional affiliation of the 
interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by non-government 
employees. Persons without a government I.D. will need to show a 
photo I.D. and sign-in at the security desk upon entering the 
building.
    Information is also available on the Institute's/Center's home 
page: www.copr.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: September 21, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-19386 Filed 9-27-05; 8:45 am]
BILLING CODE 4140-01-M